The nation of Zimbabwe has rejected a significant American healthcare agreement worth $367m (272 million pounds) over five years due to the United States' request for confidential information.
This rejection came to light after a government memo from December was leaked, indicating that President Emmerson Mnangagwa believed the deal was "unbalanced".
An official representative has since explained that the US was demanding access to genetic material for scientific study and commercial purposes but refused to share the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for more dialogue to secure a deal agreeable to all parties so the country's vital HIV treatment initiative can be sustained.
Wider Background
This rejection comes after a similar situation in Kenya, where a high court suspended a similar health funding agreement after legal challenges were filed about the security of citizens' medical information.
After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had managed assistance for the American government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and responsibility.
According to statements, Sixteen African countries have to date signed similar health pacts, constituting more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment through American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Our nation was requested to provide its biological resources and data over an extended period, with no equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Put simply, our nation would supply the raw materials for medical research without any assurance that the resulting innovations would be available to our citizens should a new pandemic arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were upending structures already established via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage potential global health emergencies.
"This framework is designed to guarantee that when a nation provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage continued dialogue with our US partners on how subsequent co-operation might be structured in a way that respects the independence and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that talks must proceed given that a large portion of the country's HIV programmes depended on international support.
"Where specific concerns exist, such as those involving information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group said.
The halted deal emphasises the continuing challenges between receiving crucial international aid and safeguarding a country's data in an ever more data-driven world.